Bondronat General Information
Bondronat (generic name: ibandronic acid / ibandronate sodium; brand names include: Idrofos / Bondronat / Bonviva) is used to treat or prevent osteoporosis in women after menopause.
Bondronat is designed to decrease activity of the cells that cause bone loss after menopause, with just one tablet a month. Bondronat helps slow or stop the natural processes that dissolve bone tissue; it binds with and stays in your bones throughout the month.
In fact, Bondronat is clinically proven to not only maintain bone density, but actually works with your body to help reverse bone loss. In clinical studies, 9 out of 10 women had improved bone density after 1 year on Bondronat.
Bondronat may also help lower the chances of breaking bones (fractures).
Follow the directions for using this medicine provided by your doctor. Take Bondronat exactly as directed.
Bondronat 150 mg tablets are taken once a month. Choose one date of the month (your Bondronat day) that you will remember and that best fits your schedule to take your Bondronat 150 mg tablet.
Take Bondronat first thing in the morning.
Wait at least 1 hour (60 minutes) before eating or drinking anything except plain water.
Swallow Bondronat whole (do not chew or suck) with at least 6 to 8 ounces (1 cup) of plain water.
Do not take Bondronat with mineral water, sparkling water, coffee, tea, milk, or juice.
Avoid taking any other oral medicine, including calcium, antacids, or vitamins, for at least 60 minutes after taking Bondronat.
Avoid lying down for at least 60 minutes after taking Bondronat to help decrease the risk of problems in the esophagus and stomach.
Tell your doctor before taking Bondronat, if:
you are allergic to any medicines;
you have low blood calcium or kidney problems;
you are pregnant or breast-feeding.
Active ingredient: ibandronate sodium.